Megan Sniecinski

Companies

• Praxis Precision Medicines, Inc.Chief operating officer Jan 9, 2026 to now¹
• BioCryst PharmaceuticalsChief Business Officer Jul 3, 2019 to Dec 17, 2020²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• PPPraxis Precision Medicines, Inc. PRAX28,664 shares³$7.4M at $259.50May 14, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• May 14, 2026Granted 89 shares at $167.94 of Praxis Precision Medicines, Inc.³
• Jan 12, 2026Shares withheld for tax 885 shares at $275.74 of Praxis Precision Medicines, Inc.⁴
• Jan 10, 2026Shares withheld for tax 1,087 shares at $288.45 of Praxis Precision Medicines, Inc.⁵
• Jan 8, 2026Granted 9,625 shares of Praxis Precision Medicines, Inc.⁵